Sign In

Barbara Stoltenborg

Barbara Stoltenborg is currently the Associate Director of Global Oncology Finance at Novartis. In this role, she is responsible for overseeing financial strategies and operations related to oncology projects within the company. Her expertise lies in strategic finance and communication, where she is recognized for building strong relationships and facilitating efficient project management.12

Before her tenure at Novartis, Stoltenborg worked at Johnson & Johnson as a Manager in Technology Finance from 2023 onwards, following her position as Associate Director at Novartis from 2019 to 2023.23 Her professional background indicates a strong foundation in financial management within the pharmaceutical industry, particularly in oncology, which is a critical area of focus for Novartis.

Stoltenborg's LinkedIn profile highlights her capabilities as a strategic finance partner, emphasizing her ability to communicate effectively and navigate complex financial landscapes.1

Highlights

Epigenetic and Transcriptional Networks Underlying Atrial Fibrillation

Related Questions

What are Barbara Stoltenborg's main responsibilities at Novartis?
How long has Barbara Stoltenborg been working in the pharmaceutical industry?
What specific projects has Barbara Stoltenborg led in Global Oncology Finance?
What is Barbara Stoltenborg's educational background?
How has Barbara Stoltenborg contributed to the development of new oncology treatments?
Barbara Stoltenborg
Add to my network

Location

Mendham, New Jersey, United States